SmartHealth Catalyzer — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
32 BiosciencesMay 2024
Focuses on gastrointestinal disease treatment and prevention by restoring the GI mucosal-immune system with a first-in-class therapeutic.
BiotechIllinois, US
Joseph Francis Pierre(Director)Brian Yoor(Director)Eugene Chang(Director)Jaime Contreras(Director)John C. Alverdy(Director)Peter Farmakis(Executive Officer, Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.